Vident Advisory’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,600	Closed	-$274K	–	1442
2024 Q1	$274K	Buy	+8,600	New	+$274K	0.01%	1083
2023 Q4	–	Sell	-10,574	Closed	-$135K	–	1335
2023 Q3	$135K	Buy	+10,574	New	+$135K	﹤0.01%	1176